2011-07-17 watchlist: companies with near term catalysts

1. $ANX (Adventrx Pharmaceuticals) 

• PDUFA 9/1
• Recent pullback
• Options available as of Friday, July 15
• Sept call options expire after PDUFA

2. $CLSN (Celsion Corporation)

• Interim data expected in third quarter, 2011 (Jul - Sept)
• Phase 3 trial (HEAT) under Special Protocol Assessment (SPA)
• ThermoDox granted FDA Organ Drug status
• Potential rolling NDA filing (Fast Track Designation) in 2011 pending upcoming interim results

3. $SGEN (Seattle Genetics)

• Company's late stage chemotherapy, Adcetris, received unanimous support (10-0) on Thursday from FDA advisory panel for accelerated approval in TWO indications: a) Hodgkin lymphoma who relapse after autologous stem cell transplant and b) elapsed or refractory systemic anaplastic large cell lymphoma (ALCL)
• Near term PDUFA 8/30 
• Over selling on Friday due to 'sell the news' market psychology 
• Potential short term 'Hike' to PDUFA